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During	June	9–September	30,	2015,	five	cases	of	 louse-
borne	 relapsing	 fever	were	 identified	 in	Turin,	 Italy.	All	 5	
cases	were	 in	young	 refugees	 from	Somalia,	2	of	whom	
had	lived	in	Italy	since	2011.	Our	report	seems	to	confirm	
the possibility of local transmission of louse-borne relaps-
ing fever.
Louseborne relapsing fever (LRF) was once widely distributed in all geographic areas, including Europe 
and North America, occurring in association with poverty 
and overcrowding. In Europe, it virtually disappeared af-
ter World War I in parallel with improved living conditions 
that led to substantially decreased body lice infestations in 
humans (1). Currently, LRF is reported mostly from Ethi-
opia and surrounding countries, where it is endemic (2): 
in this region, it is an extremely common infection with 
substantial mortality. The causative agent is the spirochete 
bacterium Borrelia recurrentis. In nature, the only relevant 
vector is the body louse, which feeds only on humans; no 
other reservoir for this infection is known (1,3). The incu-
bation period is 3–12 days. We report 5 cases of LRF in ref-
ugees to Italy from East Africa that occurred during 2015.
The Cases
All 5 patients were young men from Somalia (Table). Pa-
tients 1, 4, and 5 had recently arrived in Italy after trav-
eling from Somalia through Kenya, Uganda, and Sudan 
to Libya, where they boarded a boat to Sicily (Figure 
1). Patients 2 and 3 had resided in Italy since 2011, and 
both denied any travel outside Europe in the past 4 years. 
These 2 men lived in the same building in Turin, occupied 
by ≈600 refugees of different nationalities, most of them 
from Somalia. Patients 4 and 5 also reported a short stay 
in the same building.
All patients sought care at one of the city emergency 
departments (EDs), reporting a 2–4-day history of fever 
with chills and headache. Other common symptoms in-
cluded vomiting, myalgia, and abdominal pain. One patient 
had diarrhea.
Routine blood exams, performed on all 5 men, showed 
marked thrombocytopenia (22,000–48,000/μL) and el-
evated C-reactive protein (values 16–115 times the upper 
reference value). Procalcitonin, measured in 3 patients, was 
markedly increased (11.4–21 ng/mL [reference <0.5 ng/
mL]). Liver function tests and bilirubin were either normal 
or slightly elevated.
All patients were transferred to the Infectious Disease 
Hospital in Torino for further assessment. Giemsa-stained 
thin and thick blood smears were negative for malaria para-
sites but showed spirochetes (Figure 2). LRF was suspect-
ed, and the patients were treated with either doxycycline 
alone or doxycycline plus ceftriaxone. Patients 1 and 5 
showed an acute febrile reaction after the first antimicrobial 
dose: symptoms were compatible with a Jarisch-Herxhei-
mer reaction (JHR).
No lice were found on the patients or on their clothes; 
patient 5 had skin lesions caused by scratching. None of 
the patients had rash or bleeding as described in the lit-
erature (3). Hepatomegaly was not observed; only patient 
4 showed an enlarged spleen at ultrasound. Tachycardia 
was common, but alterations of cardiac function were not 
observed (no murmurs, corrected QT interval in normal 
range). A low systolic blood pressure (<90 mm Hg) was 
observed only in patient 4.
Bacterial DNA was extracted from 200 μL of blood 
from each of the 5 patients by using the QIAmp Mini Kit 
(QIAGEN, Hilden, Germany) and was detected amplify-
ing the 16S rRNA. Nucleotide sequences of PCR products 
were determined. Sequences were identified by BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). B. recurrentis 
was identified in all patients, showing 100% identity with 
sequences of B. recurrentis reference strain A1 (GenBank 
accession nos. NR074866 and CP000993).
Italy has recently received large numbers of refugees 
from East Africa, particularly from Somalia. These refugees 
come from and travel through countries where B. recurren-
tis is endemic; along the way, they are often sheltered in 
crowded conditions with very poor hygienic facilities. Two 
of the patients reported here indicated that, while staying in 
Libya, they were held with many other persons in a close 
environment, and all refugees housed together reported se-
vere itching.
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Many of these refugees enter Italy through Sicily, 
from where they are sent to reception centers throughout 
the country. Some of these reception centers have grown 
to substantial size and now house a more stable popula-
tion, with continuous input of new arrivals. In these condi-
tions, local transmission can occur with a possible risk for 
epidemics: 2 of the 5 patients reported here were long-term 
residents in Italy, and they denied recent travel to Africa, so 
they probably acquired the infection while being housed in 
the same facilities as the newly arrived refugees. Although 
it is possible that they denied recent travel for fear of legal 
consequences, they are unlikely to have had the opportu-
nity to travel out of Europe for economic reasons.
We did not find any louse on the body or in the 
clothing of these patients. However, we identified B. 
recurrentis by gene sequencing, and the dynamic of 
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Table. Characteristics	of	louseborne	relapsing	fever	among	East	African	refugees,	Italy,	2015* 
Characteristic Patient	1 Patient	2 Patient 3 Patient	4 Patient 5 
Time from arrival in Italy 3 d 4	y 3 y 10	d 10	d 
Age, y 20 27 31 20 26 
Date of admission Jun	9 Jul	28 Sept 5 Oct	1 Sept	29 
Date of symptom onset Jun	7 Jul	24 Sept	1 Sept	27 Sept	26 
Symptom      
 Fever Yes Yes Yes Yes Yes 
 Abdominal pain No No Yes Yes No 
 Vomiting Yes Yes Yes Yes No 
 Diarrhea No No Yes No No 
 Headache Yes Yes Yes Yes Yes 
 Myalgia No Yes No No Yes 
 Other None Lumbar pain None Cough Chest pain, itching 
Laboratory test (reference)      
 Platelets	(>150,000/μL) 32,000 47,000 22,000 41,000 2,9000 
 Bilirubin	(<1.2	mg/dL) 2.3 1.8 3.9 4.2 1.8 
 Liver function† Normal Normal AST ×4; ALT ×3 AST ×3; ALT 
normal 
Normal 
 Prothrombin	time	(>70%) 78% 66% 68% 100% 70% 
 CRP† ×16 ×56 ×95 ×115 ×59 
 Procalcitonin	(<0.5) 11.36 NA 21 11.9 NA 
 QTc	(<440	msec) 428 361 423 391 414 
 PCR for Borrelia recurrentis Positive Positive Positive Positive Positive 
Treatment Doxycicline Doxycicline Doxycicline Doxicicline	+	
ceftriaxone 
Doxycicline,	switched	
to	ceftriaxone 
Jarisch-Herxheimer reaction Yes,	mild Not	observed Not	observed Not	observed Yes,	moderate 
*ALT, alanine aminotransferase; AST, aspartate aminotransferase; CRP, C-reactive	protein;	NA,	not	available;	QTc,	corrected	QT	interval. 
†Indicated as normal (within reference value) or × upper reference value. 
 
Figure 1. Route (arrows) 
followed by refugees from 
Somalia to Libya, where they 
boarded	a	boat	to	Sicily.	Gray	
shading indicates Borrelia 
recurrentis–endemic	countries.
DISPATCHES
transmission we postulate in our cases fits more closely 
the model of louse transmission (overcrowding, poor 
hygienic conditions, migration) than that of tick trans-
mission (1,3,4). Lice are relatively short-lived and re-
main infected throughout their lives but cannot transmit 
borreliae to their progeny. They do not inject borreliae 
directly while feeding (infection takes place when they 
are crushed on skin) (1): infected lice can survive on 
uninfected persons but, when moved to other persons, 
give rise to infection. Thus, identifying a direct chain of 
transmission is often challenging. The presence of lice 
has been reported as a growing problem in western Eu-
rope homeless persons with no history of travel, threat-
ening an alarming scenario (4,5).
All 5 patients reported here sought care at one of 
the EDs in Turn for fever associated with other non-
specific symptoms; all 5 diagnoses were made as oc-
casional observations of spirochetes on thin and thick 
blood smears conducted to search for malaria parasites. 
These 5 patients might represent a minority of persons 
who are actually affected by relapsing fever. In fact, in 
many instances, persons seen at an ED for fever, espe-
cially persons without a history of recent travel to malaria- 
endemic countries, would not be investigated for malaria 
and would probably be treated empirically with antimicro-
bial drugs, leading to resolution of symptoms without fur-
ther investigations.
Two of the patients we report had symptoms sugges-
tive of a JHR. JHR is an acute, febrile reaction, potentially 
fatal, occurring shortly after starting antimicrobial drugs, 
probably attributable to the release of cytokines associ-
ated with clearance of borreliae from blood (2,6). A higher 
frequency of JHR has been reported in the literature, up 
to 80% (6,7), with some differences depending on the an-
timicrobial drug used (7,8). However, most observations 
were performed in LRF-endemic countries. These patients 
were all hospitalized and were receiving supportive treat-
ment (intravenous rehydration and paracetamol, either in-
travenously or orally, to control headache, myalgia, and 
abdominal pain), which might have played a role in avoid-
ing JHRs or in reducing its symptoms. Several studies have 
been conducted on possible preventive options to avoid the 
arousal of JHR, but results have not been consistent (9). 
Some clue of a possible action of paracetamol on the devel-
opment of JHR has been reported (8).
Conclusions
In summary, we identified B. recurrentis infection in 5 pa-
tients in Italy who were refugees from East Africa; 2 of 
these patients had not traveled outside Italy for several 
years. Beginning in July 2015, several reports from coun-
tries in Europe have described relapsing fever in refugees 
from East Africa (10–13). In some of these cases, transmis-
sion might have occurred during transit through Italy (12). 
Our findings confirm the possibility of local transmission 
of LRF caused by B. recurrentis.
Dr. Lucchini is an infectious disease specialist at the Hospital for 
Infectious Diseases in Turin. Her primary research interests in-
clude sexually transmitted infections, HIV, and tropical diseases 
in travelers.
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